By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Provectus Biopharmaceuticals Inc. 

7327 Oak Ridge Highway Suite B

Knoxville  Tennessee  37931  U.S.A.
Phone: 866-594-5999 Fax:


SEARCH JOBS








Company News
Provectus Biopharmaceuticals Inc. Begins Recruitment For Phase 2 Mechanism Of Action Clinical Trial Of PH-10 For Psoriasis 1/29/2015 10:44:57 AM
Provectus Biopharmaceuticals Inc.’ Novel Synthesis Patent Application Allowed By Chinese Patent Office 1/26/2015 10:02:53 AM
Provectus Biopharmaceuticals Inc.’ Protocol For Phase 2 Study Of Mechanism Of Action Of PH-10 On Immunologic Makers Of Psoriasis Now Available Online 12/23/2014 10:36:24 AM
Provectus Biopharmaceuticals Inc. To Meet With FDA On Operational Aspects Of PV-10 Phase 3 Melanoma Study With Aim To Maximize Speed Of Enrollment 12/22/2014 11:45:42 AM
Provectus Biopharmaceuticals Inc. To Sponsor American Association Of Physicians Of Indian Origin 12/17/2014 8:21:06 AM
Provectus Biopharmaceuticals Inc. Extends Memorandum Of Understanding With Sinopharm-China State Institute Of Pharmaceutical Industry And Sinopharm A-THINK Pharmaceutical Co., Ltd 11/14/2014 10:42:21 AM
Provectus Biopharmaceuticals Inc.’ Protocol For Phase 3 Study Of PV-10 As Treatment For Melanoma Now Available Online 11/13/2014 10:50:46 AM
Provectus Biopharmaceuticals Inc. Submits PV-10 Phase 3 Melanoma Protocol To FDA 11/7/2014 9:46:50 AM
Provectus Biopharmaceuticals Inc. Reports Third Quarter Results 11/7/2014 9:27:36 AM
Provectus Biopharmaceuticals Inc. Announces Abstract Available On Intralesional PV-10 And Co-Inhibitory Blockade Data For SITC 29th Annual Meeting 11/7/2014 9:09:31 AM
12345678910...
//-->